Rapid bone loss is associated with increased levels of biochemical markers

Journal of Bone and Mineral Research

Volumn 13, Issue 2, 1998, Pages 297-302

  Ross, Philip D ^a   Knowlton, William ^a  

^a Hawaii Osteoporosis Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; PYRIDINOLINE;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE TURNOVER; FEMALE; FRACTURE; HUMAN; MAJOR CLINICAL STUDY; OSSIFICATION; OSTEOPOROSIS;

EID: 0031937226     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.2.297     Document Type: Article

References (34)

1. Garnero P, Hausherr E, Chapuy M-C, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD 1996 Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study. J Bone Miner Res 11:1531-1538.
2. Vergnaud P, Garnero P, Breard G, Meunier PJ, Katayama M, Delmas PD 1996 Undercarboxylated osteocalcin (ucOC) measured with a direct and specific immunoassay predicts hip fracture (fx) in elderly women: The EPIDOS prospective study. Osteoporos Int 6 (Suppl 1):149 (abstract).
3. van Daele PLA, Seibel MJ, Burger H, Hofman A, Grobbee DE, van Leeuwen JPTM, Birkenhager JC, Pols HAP 1996 Case-control analysis of bone resorption markers, disability, and hip fracture risk: The Rotterdam study. Br Med J 312: 482-483.
4. Cummings SR, Black D, Ensrud K, Sklarin P, Arnaud C, Genant HK, Stone K, for the Study of Osteoporotic Fractures Research Group 1996 Urine markers of bone resorption predict hip bone loss and fractures in older women: The Study of Osteoporotic Fractures. J Bone Miner Res 11 (Suppl 1):128 (abstract).
5. Szulc P, Chapuy M-C, Delmas PD 1996 Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: A three year follow-up study. Bone 18:487-488.
6. van Daele PLA, Seibel MJ, Burger H, De Laet CEDH, van Leeuwen JPTM, Hofman A, Birkenhager JC, Pols HAP 1996 Evidence for uncoupling of bone formation and bone resorption in women with hip fractures: A prospective study. Osteoporos Int 6 (Suppl. 1):S199 (abstract).
7. Sklarin P, Cummings SR, Nevitt MC, Ensrud K, Stone KT, Black DM for the Study of Osteoporotic Fractures Research Group 1996 Is bone loss an independent predictor of hip fracture in elderly women with low bone mass? Presented at the International Congress of Endocrinology, San Francisco, CA, U.S.A., June, 1996.
8. Hansen MA, Overgaard O, Riis BJ, Christiansen C 1991 Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 years study. Br Med J 303:961-964.
9. Riis BJ, Hansen MA, Jensen AM, Overgaard K, Christiansen C 1996 Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up study. Bone 19:9-12.
10. Akesson K, Ljunghall S, Jonsson B, Sernbo I, Johnell O, Gardsell P, Obrant KJ 1995 Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: A retrospective and prospective population-based study of women. J Bone Miner Res 10:1823-1829.
11. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C 1988 Bone turnover in postmenopausal osteoporosis: Effect of calcitonin treatment. J Clin Invest 82: 1268-1274.
12. Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Monaco R, Gennari C 1997 The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. J Bone Miner Res 12:624-631.
13. Chesnut CH, Bell NH, Clark GS, Drinkwater BL, English SC, Johnston CC Jr, Notelovitz M, Rosen C, Cain DF, Flessand KA, Mallinak NJS 1997 Hormone replacement therapy in postmenopausal women: Urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response to bone mineral density. Am J Med 102:29-37.
14. Gonnelli S, Cepollaro C, Pondrelli C, Rossi B, Monaco R, Gennari C 1997 The usefulness of bone turnover in predicting the response to alendronate in postmenopausal osteoporosis. Bone 20:33S (abstract).
15. Riggs BL, Melton LJ III, O'Fallon WM 1996 Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone 18:197S-201S.
16. Yano K, Wasnich RD, Vogel JM, Heilbrun LK 1984 Bone mineral measurements among middle-aged and elderly Japanese residents in Hawaii. Am J Epidemiol 119:751-764.
17. Heilbrun LK, Ross PD, Wasnich RD, Yano K, Vogel JM 1991 Characteristics of respondents and nonrespondents in a prospective study of osteoporosis. J Clin Epidemiol 44:233-239.
18. Schlemmer A, Hassager C, Jensen SB, Christiansen C 1992 Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 74:476-480.
19. Eastell R, Calvo MS, Burritt MF, Offord KP, Russell RGG, Riggs BL 1992 Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 74:487-494.
20. Ju H-SJ, Leung S, Brown B, Stringer MA, Leigh S, Scherrer C, Shepard K, Jenkins D, Knudsen J, Cannon R 1997 Comparison of analytical performance and biological variability of three bone resorption assays. Clin Chem 43:1570-1576.
21. Delmas PD. Biochemical markers for the assessment of bone turnover 1995 In: Riggs BL, Melton LJ III (eds.) Osteoporosis: Etiology, Diagnosis, and Management, 2nd Ed. Lippincott-Raven, Philadelphia, PA, U.S.A., pp. 319-333.
22. Garnero P, Sornay-Rendu E, Chapuy M-C, Delmas PD 1996 Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11: 337-349.
23. Ravn P, Fledelius C, Rosenquist C, Overgaard K, Christiansen C 1996 High bone turnover is associated with low bone mass in both pre- and postmenopausal women. Bone 19:291-298.
24. Ravn P, Rix M, Andreassen, Clemmesen B, Bidstrup M, Gunnes M 1997 High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women. Calcif Tissue Int 60:255-260.
25. Johansen JS, Riis BJ, Delmas PD, Christiansen C 1988 Plasma BGP: An indicator of spontaneous bone loss and effect of estrogen treatment in postmenopausal women. Eur J Clin Invest 18: 191-195.
26. Cosman F, Nieves J, Wilkinson C, Schering D, Shen V, Lindsay R 1996 Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 58:236-243.
27. Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL1996 Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328-333.
28. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 72:367-373.
29. Slemenda C, Longcope C, Peacock M, Hui S, Johnston CC 1996 Sex steroids, bone mass, and bone loss: A prospective study of pre- peri- and postmenopausal women. J Clin Invest 97:14-21.
30. Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD 1996 Can biochemical markers predict bone loss at the hip and spine? A 4-year prospective study of 141 early postmenopausal women. Osteoporos Int 6:399-406.
31. Rosso R, Minisola S, Scarda A, Pacitti MT, Carnevale V, Romagnoli E, Mazzuoli GF 1995 Temporal relationship between bone loss and increased bone turnover: A longitudinal study following natural menopause. J Endocrinol Invest 18:723-728.
32. Schlemmer A, Hassager C, Delmas PD, Christiansen C 1994 Urinary excretion of pyridinium cross-links in healthy women: The long-term effects of menopause and oestrogen/progesterone therapy. Clin Endocrinol 40:777-782.
33. Ross PD, Davis JW, Epstein R, Wasnich RD 1991 Pre-existing fractures and bone mass predict vertebral fracture incidence. Ann Intern Med 114:919-923.
34. Marshall D, Johnell O, Wedel H 1996 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J 312:1254-1259.